Low Dose Computed Tomography for Lung Cancer Screening



Status:Enrolling by invitation
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:11/14/2018
Start Date:August 14, 2017
End Date:December 2021

Use our guide to learn which trials are right for you!

Smoking Cessation in Lung Cancer Screening: Integrated Digital/Clinical Approach

This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that
links LDCT-eligible smokers with an evidence-based intervention comprised of a web-based
program and integrated text messaging. The goal is to provide actionable findings about how
to most effectively and cost efficiently promote abstinence in LDCT clinics.

Using a 3-arm randomized trial design with repeated measures at 1, 3, 6, and 12 months, the
study will randomize N=1650 smokers who present for LDCT lung cancer screening to an passive
referral usual care control condition, proactive referral to a digital cessation intervention
that combines web and text messaging, or proactive referral to a digital cessation
intervention combined with Tobacco Treatment Specialist counseling. The Study will examine
overall effectiveness of the interventions in promoting abstinence, the impact of proactive
referral to treatment, and the total cost and cost effectiveness of the interventions. The
Study will also examine the representativeness of the enrolled sample and explore barriers
and facilitators to intervention adoption with LDCT clinic leaders. The trial is structured
as a practical clinical trial to answer key questions of direct relevance to LDCT
decision-makers.

Inclusion Criteria:

1. Scheduled for LDCT screening

2. Current smoking (every day/some days)

3. At least weekly use of the Internet

4. Current ownership of cell phone with a text messaging plan

5. Willing to receive study text messages.

6. Ability to complete all aspects of the study

7. Ability to provide signed informed consent

Exclusion Criteria:

1. Current (in the past 30 days) use of tobacco cessation medication or participation in
tobacco cessation treatment.

2. Those with a condition deemed by the investigators to be exclusionary to the study
We found this trial at
1
site
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials